Our Deals
Deals
GQ Life Sciences acquired by Aptean October 3, 2016
Overview
Aptean, a leading provider of mission critical enterprise software solutions, announced its acquisition of GQ Life Sciences on October 3, 2016.
GQ Life Sciences is a best-in-class patent search solution, fueled by the world’s largest database of over 345 million biological sequences.
Significance
The acquisition of GQ Life Sciences expands Aptean’s ability to provide vertically-focused mission critical enterprise solutions by entering the Life Sciences and Big Data markets, where there are significant growth opportunities.
Aptean will leverage GQ Life Science’s database of over 15 million patents to enhance its ERP offerings.
As part of Aptean, GQ Life Sciences will have the opportunity to expand the development of its proprietary search algorithms and database model to create richer search options and deeper insights for the patent searcher and scientific researcher.
Crosstree’s Role
Financial advisor to GQ Life Sciences.